Professional Documents
Culture Documents
Zeamays
Zeamays
Zeamays
net/publication/331546079
CITATION READS
1 224
3 authors:
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Assist.Prof.Dr. Mays Hadi Jebur on 17 May 2019.
Mohammed Abdul-Hassan AL-Zobaidy1, Mays Hadi Jebur2, Nada Khazal Kadhim Hindi3
1
Department of Basic Medical Sciences/ College of Nursing/ University of AL-Qadisiyah, Iraq, 2Basic and Medical
science Department, College of Nursing, University of Babylon, 3Basic and Medical science Department, College
of Nursing, University of Babylon
ABSTRACT
Background: Urinary tract infection costs hundreds millions of dollars every year. In addition, causative
bacterial species are diverse and some of them are multi-drug resistant. Objectives: evaluating the effects
of aqueous extracts of Zea Mays, Cranberry and Raisins on growth, adherence and biofilm formation of
bacterial uropathogens isolated from clinical urinary tract infections. Method: The extracts of Zea Mays,
Cranberry and Raisins were prepared as 30 gram of powder soaked in 100 ml distillated water, allowed
to stand for 72 hr and sterilized by filtration. Bacterial isolates were obtained from urinary tract infection
clinical samples. Agar well diffusion assay, tissue culture plate method assay and bacterial ability to adhere to
oral epithelial cells used to evaluate effects of these extracts on growth, motility, adhesion and biofilm formation
in bacterial isolates. Results: the aqueous extracts of Zea Mays, Cranberry and Raisins, individually and
in combination, have significant inhibitory effects on growth, motility, adherence and biofilm formation in
the bacterial isolates considered in current study. In addition, combinations that contain Zea Mays exerted
more powerful antibacterial effects than other combinations. Conclusions: plant extracts considered in
current study may provide useful substitutes for commonly utilised antibiotics for treatmnet of urinary tract
infections, especially recurrent cases. However, the exact mechanisms and the active ingredients responsible
for the reported antibacterial effects need further exploration and specification. In addition, further studies at
the molecular level and/ or in vivo studies involving humans and animals are needed to confirm the observed
effects of these plant extracts.
Figure (4): Antibacterial activity of white Raisins and Cranberry against bacterial isolates
Figure (5): Antibacterial activity of Zea Mays and Cranberry against bacterial isolates
Figure (6): Antibacterial activity of Zea Mays, white Raisin and against bacterial isolates
Indian Journal of Public Health Research & Development, February 2019 2018, Vol. 10, No. 02 859
Table (1) Effects of individual extracts of Raisins, Cranberry and Zea Mays on growth of G+ve and G-ve
bacterial uropathogenes
Table (2) Effects of combinations of Raisins, Cranberry and Zea Mays extracts on growth of G+ve and G-ve
bacterial uropathogenes
Table (3) Anti-biofilm and anti-adherence activities of Zea Mays, white Raisin and Cranberry against G-ve
bacteria
3. Nielubowicz GR, Mobley HL. Host–pathogen 14. Bolin, H., Petrucci, V., Amino acids in raisins. J.
interactions in urinary tract infection. Nature Rev Food Sci. 1985; 50, 1507.
Urol. 2010; 7:430–441. Ronald A. The etiology of 15. Palma, M., Taylor, L.T., Supercritical fluid
urinary tract infection: traditional and emerging extraction of 5-hydroxymethyl-2- furaldehyde from
pathogens. Am J Med. 2002; 113 (Suppl 1A):14S– raisins. J. Agric. Food Chem. 2001; 49, 628–632.
19S. 16. Rahbar M, Diba K . In vitro activity of cranberry
4. Kostakioti M, Hadjifrangiskou M, Hultgren extract against etiological agents of urinary tract
SJ. Bacterial biofilms: development, dispersal, infections. African Journal of Pharmacy and
and therapeutic strategies in the dawn of the Pharmacology 2010; 4(5), 286-288, May 2010.
postantibiotic era.Cold Spring Harb Perspect Med. 17. Gunther NW, Lockatell V, Johnson DE, Mobley HL
2013 ;1;3(4):a010306. . In vivo dynamics of type 1 fimbria regulation in
5. Danese PN, Pratt LA, Dove SL, Kolter R. The outer uropathogenic Escherichia coli during experimental
membrane protein, antigen 43, mediates cell-to-cell urinary tract infection. Infect. Immun. 2001; 69:
interactions within Escherichia coli biofilms. Mol 2838–2846
Microbiol. 2000; 37:424–432. 18. Hindi NKK. In vitro Antibacterial
6. Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai activity of Plants extracts against
K. Urinary tract infections caused by Pseudomonas Porphyromonasgingivalis, Prevotellaintermedia
aeruginosa: a mini review. J Infect Publ Health. and Aggregatibacteractinomycetemcomitans
2009; 2:101–111. Streptococcus mutanus, Isolated from Periodontitis
7. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Patients in Babylon province, Iraq. International
Filamentation by Escherichia coli subverts innate Journal of PharmTech Research, 2016; 9(11):84-93.
defenses during urinary tract infection. Proc Natl 19. Forbes BA, Sahm DF, Weissfeld AS. Bailey and
Acad Sci USA. 2006; 103:19884–19889. Scotts’ Diagnostic microbiology. 12th ed. Elsevier.
8. Nagamatsu K, et al. Dysregulation of Escherichia China.2007.
coli α-hemolysin expression alters the course of 20. Christensen GD, Simpson WA, Younger JA,
acute and persistent urinary tract infection. Proc Baddour LM, Barrett FF, Melton DM. Adherence
Natl Acad Sci USA. 2015; 112:E871–E880. of cogulase negative Staphylococi to plastic tissue
9. Kostakioti M, Hultgren SJ, Hadjifrangiskou M. cultures:a quantitative model for the adherence
Molecular blueprint of uropathogenic Escherichia of staphylococci to medical devices. J Clin
coli virulence provides clues toward the development Microbiol.1985; 22:996–06.
of anti-virulence therapeutics. Virulence. 2012; 21. Avila-Campos MJ, Simionato MR, Cai S, Mayer
3:592–594. MP, Delorenzo JL, Zelant F. Virulence Factors
10. Khadim WA, Khadim MJ, Hameed IH. Antibacterial of Actinobacillus actinomycetecomitans: other
activity of several plant extracts against proteus Putative Factors. Pesq.Odont. Bras.2000; 14(1): 05-
species. International Journal of Pharmaceutical and 11
Clinical Research 2016; 8(12): 1673-1684. 22. Harkins KJ . what’s the use of cranberry juice? Age
11. Solihah, M.A., Wan Rosli, W.I. and Nurhanan, A.R. and Ageing, 2000; 29: 9- 12.
Phytochemicals screening and total phenolic content 23. Mulvey MA.Adhesion and entry of uropathogenic
Indian Journal of Public Health Research & Development, February 2019 2018, Vol. 10, No. 02 861
Escherichia coli. Cell Microbiol. 2002; 4(5):257– Grün, S.; Winklmair, A.; Eisenreich, W.; Bacher,
271. A.; Meeley, R.B.; Briggs, S.P.; et al. Analysis of
24. Dugoua JJ, Seely D, Perri D, Mills E, Koren a chemical plant defense mechanism in grasses.
G.Safety and efficacy of cranberry (Vaccinium Science 1997, 277, 696–699.
macrocarpon) during pregnancy and lactation. Can. 32. Niemeyer, H.M. Hydroxamic acids derived from
J. Clin. Pharmacol., 2008; 15: 80-86. 2-hydroxy-2H-1,4-benzoxazin-3(4H)-one: Key
25. Cimolai N, Cimolai T The cranberry and the urinary defense chemicals of cereals. J. Agric. Food Chem.
tract. Eur. J. Clin. Microbiol. 2007; 26: 767-776. 2009, 57, 1677–1696.
26. Johnson BJ, Lin B, Rubin RA, Malanoski AP Media 33. Wei, Q., Wolf-Hall, C., and C. A. Hall III. Application
acidification by Escherichia coli in the presence of of raisin extracts as preservatives in liquid bread
cranberry juice., 2009; 2(226): 1-4. systems. J. Food Sci. 2009; 74: M177-M184.
27. Wang SY, Stretch AW. Antioxidant capacity in 34. United States Department of Agriculture (USDA).
cranberry is influenced by cultivar and storage 2009. Pathogen Modeling Program Version 7.0.
temperature. J Agric Food Chem 2001; 49: 969–974. Available at http://pmp.arserrc.gov/PMPOnline.
aspx
28. MacMicking J, Xie QW, Nathan C. Nitric oxide and
macrophage function. Annu Rev Immunol 1997; 15: 35. Aruscavage, D., Lee, K., Miller, S., and J. T. LeJune.
323–350. Interactions affecting the proliferation and control
of human pathogens on edible plants. J. Food
29. Howell AB, Leahy M, Kurowska E, Guthrie N. In
Sci.2006; 71: 89-99.
vivo evidence that cranberry proanthocyanidins
inhibit adherence of p-fimbriated E. coli bacteria to 36. Vasavada, M. N., and D. P. Cornforth. Evaluation
uroepithelial cells. Fed Am Soc Exp Biol J 2001; of antioxidant effects of raisin paste in cooked
15: A284. ground beef, pork, and chicken. J. Food Sci. 2006;
71: C242-C245.
30. Yue, Q.; Bacon, C.W.; Richardson, M.D.
Biotransformation of BOA and 6-methoxy- 37. Tamma PD, Cosgrove SE, Maragakis LL
benzoxazolinone by Fusarium moniliforme. Combination Therapy for Treatment of Infections
Phytochemistry 1998, 48, 451–454. (CrossRef). with Gram-Negative Bacteria. J Clinical
Microbiology Reviews; 2012; 25(3): 450–470.
31. Frey, M.; Chomet, P.; Glawischnig, E.; Stettner, C.;